We are at an interesting stage, v1 of clio daye is in the app store, we've just submitted v1.1.1 which includes accessibility, i18n, l10n and translations to DE/FR/es-MX - this is the roadmap we have for a v2 can you review and give your opinion. Only call out something if it makes sense as a ground stages 

This is a strong, opinionated v2. It doesn’t feel like feature creep, it feels like a reframing of the product category, which is exactly what you want at this stage. I’m going to stay disciplined to your ask and only call out things that matter as ground-stage decisions (things that materially affect trajectory, not polish).

What you got very right (and should not second guess)

Before pushing on anything, a few foundational calls here are correct at a product strategy level:

Life-stage as a first-class primitive (user-declared, never inferred)
This is not just UX, it’s your trust moat. Do not compromise this later.
Sensemaking > prediction shift
This is the real product. Everything else supports this.
“Value on day one without historical data”
This is the unlock for menopause + churn recovery users. Most competitors fail here.
Unexpected bleeding handling philosophy
Accept → store → surface context. No blocking, no diagnosis. This is exactly right.

None of those need adjustment.

Ground-stage calls I would challenge / refine
1. You’re still slightly over-indexed on “cycle adjacency”

You’ve done a good job expanding beyond cycles, but there’s still a subtle gravitational pull back to them:

“Time since last bleed”
Cycle remnants in menopause view
Forecast zone existing conceptually across all stages

Why this matters (early-stage risk):
If you don’t fully break from cycle-centric thinking in menopause/paused, you’ll:

Confuse new users (“this still feels like a period app”)
Limit long-term expansion into broader health tracking

Ground-stage adjustment:
Make a hard internal rule:

Menopause and paused are non-cycle products, not degraded cycle modes.

Concretely:

Remove any cycle framing from menopause home (even subtle references)
Treat menopause as symptom + pattern system only
Think of it as a different product that happens to share infra

This is a philosophical boundary that will prevent future design drift.

2. “Your Month” is the product — but you’re shipping it too late

You’ve positioned it correctly:

“Not charts — a read”

That’s the core differentiator.

But you’re putting it in v2.1, which means:

Users won’t feel the v2 shift immediately
You risk v2.0 feeling like “settings + taxonomy update”

Ground-stage adjustment:

Ship a thin version in v2.0, even if it’s incomplete.

Not the full feature, just:

A basic “This week” or “So far” summary

Even if it says:

“You’ve logged 5 days. Here’s what we’re starting to see…”

Why:

Reinforces the sensemaking positioning immediately
Creates habit loop early
Makes Daily Wellbeing fields feel purposeful

If you delay this, you delay the perceived product leap.

3. Daily Wellbeing fields — you’re underestimating their weight

These look simple:

Sleep
Energy
Stress

But they are actually:

Your future universal data layer across all life stages

Right now they’re treated as a small addition.

Ground-stage risk:
If they’re:

Too lightweight → low signal quality
Too optional → sparse data → weak summaries

Ground-stage adjustment:

Treat them as a core primitive, not a helper:

Consider subtle defaults (e.g. mid-value preselected)
Or tap-based “quick log” patterns (no thinking required)
Or progressive fill (tap once to accept yesterday’s baseline)

Goal:

Make logging these feel effortless, almost automatic

Because:

They power “Your Month”
They unify all life stages
They become your longitudinal dataset

If this layer is weak, everything downstream is weaker.

4. Genitourinary (GSM) handling — you’re close, but this is a trust moment

You’ve done the right thing with opt-in.

But this is more than a category toggle.

This is a psychological boundary for users:

Shame
Privacy sensitivity
Medical ambiguity

Ground-stage risk:
If introduced too clinically or abruptly:

Users won’t opt in
Or worse, they churn

Ground-stage adjustment:

Frame GSM not as:

“Genitourinary tracking”

But as:

“Intimate health (optional)”

And:

Introduce it contextually (not just settings)
Possibly after a few sessions of trust building
Use softer language in onboarding copy

This is not a UI decision, it’s a trust ramp decision.

5. Paused stage — you’re under-defining it

Paused is currently:

Postpartum
Breastfeeding
“Taking a break”

That’s actually three different psychological states:

Scenario	User mindset
Postpartum	Recovery, overwhelm
Breastfeeding	Hormonal uncertainty
Taking a break	Intentional disengagement

Ground-stage risk:
One generic “paused” mode may feel:

Too vague
Not supportive enough

Ground-stage adjustment (lightweight):

Don’t split the stage yet, but:

Slightly tailor copy based on entry path
Or capture why they paused (1-tap)

Even just:

“Recovering”
“Not tracking right now”

This gives you:

Better tone
Better future segmentation
Better summaries

Without adding complexity to the model.

6. Perimenopause forecasting — consider going more radical

You’re trying to soften uncertainty:

“Timing may shift”

That’s correct, but still anchored in prediction.

Ground-stage question:
Do you even want to predict here?

Because the real value is:

“Your cycle is no longer predictable — but here’s what is predictable: your patterns”

Ground-stage adjustment (strategic, not required):

Consider experimenting with:

Removing forecast prominence entirely in perimenopause
Replacing with:
“Pattern confidence”
“What tends to happen before/after symptoms”

This would be a category-defining move.

Not necessary for v2.0, but worth holding as a direction.

7. Content delivery constraint — this will bottleneck you faster than you think

You already called this out:

JSON bundled → requires app release

Given:

Multi-locale (DE/FR/es-MX)
Clinical review cycles
Rapid iteration needs

Ground-stage reality:
This will become painful within 1–2 iterations

Ground-stage recommendation:

Start designing now for:

Signed, versioned, on-device content updates
Even if you don’t ship it until v2.1

You don’t need server-driven content, but you do need:

decoupled content cadence from app releases

Otherwise:

Every wording tweak = release friction
Clinical updates = delayed
Localization = slow
One thing I would not add right now

You’re already disciplined, but worth reinforcing:

Do not add:

AI/LLM summaries (tempting given your background)
“Insights engine”
Predictive recommendations

Right now your strength is:

Clear, human-readable, non-magical interpretation

That’s rare, and it builds trust.

The core strategic read

If I zoom out, the real product you’re building is:

A private longitudinal health narrative system, starting with reproductive health but not ending there.

Your biggest risk is not missing features.

It’s accidentally:

Staying too close to “cycle tracker”
Or overcomplicating too early
Bottom line

Only a few ground-stage adjustments really matter:

Fully break cycle thinking in menopause/paused
Ship a thin “Your Month” in v2.0
Treat Daily Wellbeing as a core data layer
Handle GSM as a trust ramp, not a feature
Slightly enrich paused context
Start solving content delivery early

Everything else is well-judged and appropriately scoped.

If you get those right, v2 isn’t just an iteration, it’s a category pivot.

I want to dig deeper into the cycle adjacency, in peri stages there's still bleeding but not regularity from my understanding, isn't that important to know? 

You’re right to pause on this, because this is exactly where the product can either become more useful than anything else on the market or quietly fall back into being “a slightly better cycle tracker.”

Bleeding in perimenopause is absolutely important. The nuance is what role it plays in the system.

The distinction that matters

In earlier life stages, bleeding is:

A clock signal

It anchors the cycle
It drives prediction
It structures the entire UI

In perimenopause, bleeding becomes:

An event in a noisy system

It still matters clinically
It still matters psychologically (“something is happening”)
But it no longer reliably structures time

That’s the shift you want to reflect.

Why this matters for product design

If you treat bleeding in perimenopause like a weakened version of a cycle:

You end up with bad predictions
You reinforce a false mental model (“this should be predictable”)
You create frustration (which is exactly why Diane left Clue)

If you treat bleeding as just another symptom:

You lose important signal
You miss clinically relevant patterns (long gaps, heavy bleeding, clustering)

So neither extreme is correct.

The right framing (ground-stage decision)

Perimenopause should treat bleeding as:

A primary signal, but not a structural backbone

Concretely:

It is still highlighted and tracked distinctly
It contributes to summaries and pattern detection
But it does not drive the interface or predictions
What this looks like in Clio Daye
1. Keep bleeding prominent in logging and history

You’re already doing this well:

Flow logging remains first-class
Calendar still shows bleed events

That should not change.

Because users do care about:

“When did I last bleed?”
“How long has it been?”
“Is this normal?”
2. But remove the idea that bleeding defines “where you are”

This is where most apps fail.

Avoid framing like:

“Day 47 of cycle”
“Next period expected…”

Instead, shift to:

“Last bleed: 32 days ago”
“Bleeds have ranged from 22–55 days apart”

This keeps the information, but removes the illusion of control.

3. Treat bleeding as part of pattern detection, not prediction

This is where your Your Month feature becomes powerful.

Instead of:

Predicting next period

You surface things like:

“Bleeds have been further apart this month”
“Hot flashes increased in the 10 days before your last bleed”
“Sleep worsened after longer gaps between bleeds”

That’s far more valuable than timing.

4. Clinical significance still needs to be preserved

There are important signals tied to bleeding in perimenopause:

Very long gaps (e.g. 60+ days)
Sudden heavy bleeding
Irregular clustering

You’re already handling some of this.

The key is:

Surface it as “worth noting”, not “something is wrong”

You’ve got the tone right. Just ensure:

It’s visible enough
It doesn’t get buried in summaries
5. Forecasting: the subtle trap

You’re currently doing:

“Wider window with uncertainty”

This is reasonable, but here’s the subtle issue:

Even a wide forecast implies:

“This is still predictable, just less precise”

For some users, that’s fine.

For others, it reinforces frustration.

A cleaner mental model

Think of perimenopause as:

Layer	Role
Bleeding	Anchor events
Symptoms	Continuous signal
Time	Linear, not cyclical

You’re moving from:

Circular time (cycle)

To:

Linear time with recurring patterns

That’s the conceptual shift.

So is bleeding important?

Yes, but differently:

Important as history → “what has happened”
Important as signal → “what changed around it”
Not reliable as structure → “what will happen next”

That last one is the key.

Where I’d land (practically)

For v2, I would:

Keep bleeding highly visible in logs and calendar
Replace “cycle day” thinking with “time since last bleed”
De-emphasize or optionally remove forecasting over time
Make bleeding a first-class input into summaries, not UI structure
The deeper opportunity

If you get this right, you’re not just improving tracking.

You’re giving users something they currently don’t have:

A way to understand their body when it stops behaving predictably

That’s the moment most products abandon them.

You’re designing for that moment instead of avoiding it.

Ok what about you seem to be going back to a regular pattern? does that happen is that something to identify and call out? 

This is a very perceptive question, because it sits right on the boundary between useful pattern recognition and overpromising structure where there isn’t one.

Short answer:
Yes, it can happen that cycles appear to “settle” temporarily in perimenopause.
But treating that as a true return to regularity is where products tend to mislead people.

What actually happens biologically (in plain terms)

Perimenopause is not a smooth decline. It’s more like:

a system oscillating before it shuts down

Hormones fluctuate unevenly, which can produce:

Periods of high variability (22 → 55 → 31 days)
Followed by a few cycles that look regular again
Then disruption returns

So someone might see:

3–4 cycles that look “normal”
And think: “maybe I’m back to normal”

Clinically, that’s very common.

Why this is tricky in a product

If you say:

“You seem to be going back to a regular pattern”

You are implicitly telling the user:

This is stable
You can trust predictions again

Which is often not true.

If you ignore it completely:

You miss something the user feels (“this seems more stable lately”)
You lose credibility

So again, it’s not binary.

The right framing (ground-stage decision)

You want to detect this pattern, but describe it as:

temporary stabilization, not a return to regular cycles

That distinction matters more than it sounds.

How I would express this in Clio Daye
What you should detect

Something like:

Last 3–4 cycles fall within a tighter range
Variability has decreased compared to prior window

That’s a valid signal.

What you should say

Not:

“Your cycle is becoming regular again”
“You’re back to a normal pattern”

Instead:

“Your recent cycles have been more consistent than before”
“There’s been less variation in your cycle timing recently”

And optionally:

“In perimenopause, cycles can stabilize for a time before changing again”

This does three things:

Validates what the user is noticing
Avoids implying permanence
Educates without being clinical
Where this shows up (important)

This should not drive the home screen or predictions.

It belongs in:

“Your Month” → What we noticed
Possibly a subtle insight card

Because it’s:

observational, not actionable

Should it change forecasting?

This is the temptation.

You might think:

“If it’s stabilizing, tighten the prediction window”

I would strongly caution against doing that early.

Why:

You’ll get false confidence swings
Trust is harder to rebuild than to maintain

If anything:

You could slightly narrow language
But keep uncertainty framing intact
The deeper pattern you’re really capturing

What you’re observing isn’t “regularity returning”

It’s:

volatility decreasing temporarily

That’s a much more accurate mental model.

And it opens the door to more meaningful insights later:

“Periods of lower variability tended to follow better sleep”
“Higher stress weeks preceded more irregular cycles”

Now you’re not just tracking cycles, you’re tracking system behavior

The risk if you don’t handle this carefully

Two failure modes:

1. Overconfident system
“You’re regular again”
Predictions tighten
User gets burned again

→ Trust drops hard

2. Blind system
Ignores visible stabilization
Feels disconnected from user experience

→ Product feels dumb

The right balance

Detect it
Acknowledge it
Contextualize it
Do not anchor to it

A simple internal rule

If it helps anchor the team:

“Stability is a trend, not a state”

That one line prevents a lot of downstream mistakes in copy, forecasting, and UI.

Bottom line

Yes, it’s real and worth surfacing.
No, it should never be framed as a return to normal.

Handled correctly, this becomes one of those subtle moments where a user feels:

“This app actually understands what’s happening to me”

Handled incorrectly, it becomes:

“This app is wrong again, just like the others”

You’re very close to being on the right side of that line.